Cargando…

RF25 | PMON147 Plasma MicroRNA Expression in Phenocopy of Multiple Endocrine Neoplasia Type 1 Compared to Patients with Acromegaly and Primary Hyperparathyroidism: Potential Biomarkers of Multiple Endocrine Tumor Growth

INTRODUCTION: Changes in the expression of microRNA facilitate in the formation of various tumors. MEN1 is a rare disease caused by mutations in MEN1 gene encoding the menin protein and characterize by the occurrence of parathyroid, pituitary, gastroenteropancreatic and other tumors. If a patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trukhina, Diana, Mamedova, Elizaveta, Nikitin, Alexey, Koshkin, Philipp, Belaya, Zhanna, Melnichenko, Galina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625521/ http://dx.doi.org/10.1210/jendso/bvac150.1211

Ejemplares similares

THU081 Differences In Circulating Microrna Levels In Genetically Confirmed Multiple Endocrine Neoplasia Type 1 And Multiple Endocrine Neoplasia Type 1 Phenocopies As Assessed By Next Generation Sequencing
por: Trukhina, Diana A, et al.
Publicado: (2023)

Differences in Menin Expression in Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1, Its Phenocopies and Sporadic Acromegaly
por: Dimitrova, Diana A, et al.
Publicado: (2021)

Tissue-Specific Tumorigenesis in Multiple Endocrine Neoplasia Type I
por: Gardiner, Juliet C
Publicado: (2021)

PMON71 Evaluation of a new transition organization for young adults with endocrine or metabolic diseases
por: Roux, Enora L, et al.
Publicado: (2022)

RF13 | PMON142 Long Non-coding RNAs in Pituitary Differentiation and Endocrine Function
por: Camper, Sally, et al.
Publicado: (2022)

OR06-04 Tissue-Specific Tumorigenesis in Multiple Endocrine Neoplasia Type I
por: Gardiner, Juliet C
Publicado: (2020)

PMON127 Neuroendocrine Tumor of the Spinal Cord- A Case Report of Rare Endocrine Tumor Presentation
por: Varghese, Diana Grace, et al.
Publicado: (2022)

PMON154 Cardiovascular Complications in Acromegaly-A National Inpatient Sample Analysis
por: Thota, Geethika, et al.
Publicado: (2022)

PMON101 Fluctuating Insulin Requirements in Untreated Acromegaly: From 200-to-0
por: Bellavia, Lauren, et al.
Publicado: (2022)

PMON161 Decreased serum Wnt antagonist levels in patients with active acromegaly
por: Chen, Huan, et al.
Publicado: (2022)

SAT610 Multiple Endocrine Neoplasia Type 1 - The First Reported Case In An Indigenous Australian
por: Mignone, Edward, et al.
Publicado: (2023)

PMON61 Evaluation of elevated IGF-1 in patients without clinical evidence of acromegaly
por: Careless, Laura, et al.
Publicado: (2022)

PMON104 Sellar Gangliocytoma-Pituitary Neuroendocrine Tumor (PitNET) Presenting As Acromegaly
por: Aurora, John, et al.
Publicado: (2022)

THU094 Multiple Endocrine Neoplasia Type 1 Tumor Recurrence After Loss To Follow Up
por: Sternlieb, Sarah Jayne, et al.
Publicado: (2023)

PMON132 Biochemical and Radiologic Discordance in the Post-operative Surveillance of a Filipino Patient With Acromegaly
por: Enverga, Mariel C, et al.
Publicado: (2022)

PMON66 A Systematic Literature Review to Evaluate Extended Dosing Intervals in the Pharmacological Management of Acromegaly
por: Fleseriu, Professor Maria, et al.
Publicado: (2022)

ODP328 Longitudinal Multidisciplinary Approach for Cabergoline-Resistant Aggressive Prolactinoma Complicated by Multiple Endocrine Neoplasia Type 1
por: Furusawa, Sho, et al.
Publicado: (2022)

PMON39 A Perfect Storm – Multiple Causes of Hyponatremia in Patient With Pituitary Macroadenoma
por: Faisal, Sobia, et al.
Publicado: (2022)

PMON162 Osilodrostat Provides Sustained Clinical Benefits and Improves Health-Related Quality of Life in Patients with Cushing's Disease: Results from the Phase III LINC 4 Study
por: Feelders, Richard, et al.
Publicado: (2022)

PMON166 Safety Comparison of 40- vs 60-mg/day Doses of Oral Octreotide Capsules for Treatment of Acromegaly in the CHIASMA OPTIMAL Trial
por: Elenkova, Atanaska, et al.
Publicado: (2022)

Endocrine Dysfunction in Covid-19
por: Das, Liza, et al.
Publicado: (2021)

RF13 | PMON159 Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly: MPOWERED Trial Open-Label Extension Phase
por: Fleseriu, Maria, et al.
Publicado: (2022)

MON-313 Thyrotropin-Secreting Pituitary Tumors: Clinical Features, Diagnostic Criteria and Treatment Outcomes in 28 Patients
por: Dimitrova, Diana A, et al.
Publicado: (2020)

PMON75 Unilateral Galactorrhea in an Elderly Male
por: Monsour, Elio, et al.
Publicado: (2022)

PMON57 Impact of Injection Modalities on Real-World Injection Experience in Patients with Acromegaly or Neuroendocrine Tumors (NETs) Treated With Somatostatin Analog (SSA) Therapy: Data from the PRESTO 2 Survey
por: Ribeiro-Oliveira, Antonio, et al.
Publicado: (2022)

PMON112 Primary Pituitary Lymphoma Presenting as Apoplexy
por: Abdelaziz, Sara, et al.
Publicado: (2022)

PMON117 IGF-1 Testing: Diagnostic Pitfalls
por: Perez-Martinez, Sebastian
Publicado: (2022)

MON-457 One in Five Patients Develop Multiple Hormone Deficiencies Following Radiotherapy for Acromegaly or Cushing's Disease
por: Shen, Angeline, et al.
Publicado: (2019)

Abnormal Pituitary Imaging and Associated Endocrine Dysfunctions in Erdheim-Chester Disease
por: Shekhar, Skand, et al.
Publicado: (2021)

PMON88 A Rare Case of Composite Paraganglioma in the Bladder
por: Kreit, Helen, et al.
Publicado: (2022)

PMON89 Nephrogenic Diabetes Insipidus in a Patient on Temozolomide
por: Moll, Teresa, et al.
Publicado: (2022)

PMON155 Intraoperative, confocal laser endomicroscopy in pituitary surgery
por: Schlaffer, Sven-Martin, et al.
Publicado: (2022)

PMON70 Systemic Delivery of Leuprolide via Oral Administration
por: Shangold, Gary, et al.
Publicado: (2022)

PMON97 Pituitary Abscess: Long-term follow up
por: Hoang, Thanh, et al.
Publicado: (2022)

PMON100 IgG4 hypophysitis with granulomatous histopathology
por: Gultekin, Sakir, et al.
Publicado: (2022)

PMON90 Pituitary Abscess, A rare cause of Hypopituitarism
por: Cordeiro, Monica Fabiola Nogueira, et al.
Publicado: (2022)

PMON157 Evidence For Locally Produced Cortisol in Pituitary Tissue
por: Tsai, Karen, et al.
Publicado: (2022)

MON-306 Acromegaly Comorbidity Costs, Quality of Life, and Mortality: Lifetime Comparisons for Controlled Acromegaly, Uncontrolled Acromegaly, and the General US Population
por: Whittington, Melanie D, et al.
Publicado: (2020)

OR32-1 Endocrine Manifestations of Erdheim-Chester Disease: The Mayo Clinic Experience
por: Hurtado, Maria, et al.
Publicado: (2019)

ODP320 Immune Organs Enlarged in Acromegaly: Evaluation of Thymus Volume in Patients with Acromegaly
por: Nahit Sendur, Suleyman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ghgg1dd2vkpfd5rc51ajnd2lut